A Registry for People With T-cell Lymphoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Written informed consent

Adequate fresh or archival tumor biopsy or intent to obtain fresh tumor biopsy.

T-cell prolymphocytic leukemia

T-cell large granular lymphocytic leukemia

Disqualifiers

Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, and/or primary cutaneous acral CD8+ T-cell lymphoma not receiving systemic therapy.

Inability to collect prospective data, measure response, or perform adequate follow-up assessments in the clinical judgment of the treating physician. NOTE: Repository participation does not exclude participation in clinical trials, nor does existing clinical trial participation exclude enrollment in the study herein outlined.

Trial population

Participants at Memorial Sloan Kettering Cancer Center (MSKCC) will be recruited through the Lymphoma service in the Department of Medicine and the Department of Pediatrics. Participants will be recruited at the participating centers.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Optional Blood Sample and Nail Sample

    Other intervention

    Participants may provide optional research blood and nail samples for biobanking and future use

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: Participants with T-Cell Lymphoma1 intervention

Trial outcomes

Primary outcomes

1

Number of participants populating the T-cell Lymphoma Master Repository/TCLMR

To develop and populate a secure database comprised of patients with T-cell lymphomas with curated clinical characteristics and treatment outcomes matched to pathological biospecimens.

Time frame
10 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.